I-Mab gets new CEO after long search. Sale of the company coming next?
The drug developer filled an 18-month-long vacuum in its top position by appointing an industry veteran with a history of deal-making as its new CEO Key Takeaways: I-Mab has appointed…
Recent Articles
RELATED ARTICLES
-
Joyy stuck with unwanted China business after $3.6 billion Baidu sale collapses
YY.US -
Akeso marks profit milestone with swift rights issue
9926.HK
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
-
Kintor shares plunge after hair-loss drug flops in clinical trials
9939.HK
